Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-14

Clinical Trial Update: Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ON101 Cream for diabetic foot ulcers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ON101 Cream

Snippet

Sponsor: Oneness Biotech Co., Ltd. | Conditions: Diabetic Foot | Phase 3 | Status: COMPLETED | Results posted: 2021-04-14